- Home
- RLAY vs AXG Comparison
RLAY vs AXG Comparison
Compare RLAY & AXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- AXG
- Stock Information
- Founded
- RLAY 2015
- AXG 2021
- Country
- RLAY United States
- AXG Hong Kong
- Employees
- RLAY N/A
- AXG N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- AXG Investment Bankers/Brokers/Service
- Sector
- RLAY Health Care
- AXG Finance
- Exchange
- RLAY Nasdaq
- AXG Nasdaq
- Market Cap
- RLAY 1.0B
- AXG 692.6M
- IPO Year
- RLAY 2020
- AXG 2023
- Fundamental
- Price
- RLAY $6.15
- AXG $3.38
- Analyst Decision
- RLAY Strong Buy
- AXG
- Analyst Count
- RLAY 9
- AXG 0
- Target Price
- RLAY $16.00
- AXG N/A
- AVG Volume (30 Days)
- RLAY 2.2M
- AXG 1.0M
- Earning Date
- RLAY 11-06-2025
- AXG 06-30-2025
- Dividend Yield
- RLAY N/A
- AXG N/A
- EPS Growth
- RLAY N/A
- AXG N/A
- EPS
- RLAY N/A
- AXG N/A
- Revenue
- RLAY $8,355,000.00
- AXG $3,316,000.00
- Revenue This Year
- RLAY $27.30
- AXG $28.53
- Revenue Next Year
- RLAY $7.43
- AXG $54.60
- P/E Ratio
- RLAY N/A
- AXG N/A
- Revenue Growth
- RLAY N/A
- AXG N/A
- 52 Week Low
- RLAY $1.78
- AXG $2.91
- 52 Week High
- RLAY $7.64
- AXG $4.17
- Technical
- Relative Strength Index (RSI)
- RLAY 45.56
- AXG N/A
- Support Level
- RLAY $6.64
- AXG N/A
- Resistance Level
- RLAY $7.42
- AXG N/A
- Average True Range (ATR)
- RLAY 0.44
- AXG 0.00
- MACD
- RLAY -0.19
- AXG 0.00
- Stochastic Oscillator
- RLAY 8.31
- AXG 0.00
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.